Shares of Dr. Reddy’s Laboratories were up 3% at Rs 2,546 per share on BSE in intra-day trade as United States Food and Drug Administration (USFDA) has completed the audit of Andhra Pradesh plant with zero observations.
“The audit of our Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh by the USFDA, has been completed today with zero observations,” Dr. Reddy’s Laboratories said on Friday after market hours.
The stock of the pharmaceutical company was trading higher for the sixth straight day, up 6% from Rs 2,407 per share on November 9, as compared to 1% rise in the
“The audit of our Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh by the USFDA, has been completed today with zero observations,” Dr. Reddy’s Laboratories said on Friday after market hours.
The stock of the pharmaceutical company was trading higher for the sixth straight day, up 6% from Rs 2,407 per share on November 9, as compared to 1% rise in the